BeyondSpring Inc. (BYSI) stock
BYSINasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.45−0.11 (-19.09%)
Close on Nov 18, 2026Market cap $18.63MP/E –Yield –
BeyondSpring free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
BeyondSpring's free cash flow for the twelve months ending Jun 30, 2026 was -$16.75M. For fiscal 2025 it was -$19.82M. The highest annual figure on record is -$6.61M in fiscal 2015.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$19.82M | – |
| FY2024 | Dec 31, 2024 | -$16.67M | – |
| FY2023 | Dec 31, 2023 | -$16.57M | – |
| FY2022 | Dec 31, 2022 | -$28.19M | – |
| FY2021 | Dec 31, 2021 | -$50.09M | – |
| FY2020 | Dec 31, 2020 | -$43.80M | – |
| FY2019 | Dec 31, 2019 | -$48.17M | – |
| FY2018 | Dec 31, 2018 | -$40.16M | – |
| FY2017 | Dec 31, 2017 | -$28.87M | – |
| FY2016 | Dec 31, 2016 | -$13.76M | – |
| FY2015 | Dec 31, 2015 | -$6.61M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.77M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.28M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.50M | -676.3% |
| Q3 FY2025 | Sep 30, 2025 | -$4.19M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.87M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.25M | – |
| Q4 FY2024 | Dec 31, 2024 | $955.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.37M | -291.0% |
| Q2 FY2024 | Jun 30, 2024 | -$6.99M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.27M | – |
| Q4 FY2021 | Dec 31, 2021 | -$19.72M | – |
| Q3 FY2021 | Sep 30, 2021 | $2.81M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.23M | – |
| Q1 FY2021 | Mar 31, 2021 | -$18.95M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.98M | – |
| Q3 FY2020 | Sep 30, 2020 | -$11.48M | – |
| Q2 FY2020 | Jun 30, 2020 | -$14.28M | – |
| Q1 FY2020 | Mar 31, 2020 | -$11.06M | – |
| Q4 FY2019 | Dec 31, 2019 | -$12.68M | – |
| Q3 FY2019 | Sep 30, 2019 | -$22.38M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.04M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.06M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.43M | – |
| Q3 FY2018 | Sep 30, 2018 | -$9.68M | – |
| Q2 FY2018 | Jun 30, 2018 | -$13.10M | – |
| Q1 FY2018 | Mar 31, 2018 | -$8.95M | – |
| Q4 FY2017 | Dec 31, 2017 | -$10.19M | – |
| Q3 FY2017 | Sep 30, 2017 | -$8.25M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.14M | – |
| Q1 FY2017 | Mar 31, 2017 | -$5.29M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.21M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.51M | – |
See a number that looks wrong?